• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与传统观念相反,在一项试验得出一种乳腺癌治疗方法无效的结论后,医生们放弃了该治疗方法。

Contrary To Conventional Wisdom, Physicians Abandoned A Breast Cancer Treatment After A Trial Concluded It Was Ineffective.

作者信息

Howard David H, Soulos Pamela R, Chagpar Anees B, Mougalian Sarah, Killelea Brigid, Gross Cary P

机构信息

David H. Howard (

Pamela R. Soulos is a program manager and data analyst at the Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center at the Yale University School of Medicine and the Yale Cancer Center, in New Haven, Connecticut.

出版信息

Health Aff (Millwood). 2016 Jul 1;35(7):1309-15. doi: 10.1377/hlthaff.2015.1490.

DOI:10.1377/hlthaff.2015.1490
PMID:27385249
Abstract

Conventional wisdom holds that physicians are slow to abandon ineffective medical practices. We evaluated this theory in the case of axillary lymph node dissection, a procedure to remove the lymph nodes near the breast to prevent the spread of breast cancer following breast-conserving surgery. A major trial conducted from 1999 to 2004, with results presented in 2010 and published in 2011, found that patients who met certain criteria could forgo axillary lymph node dissection. Using cancer registry data, we estimated that the proportion of patients undergoing axillary dissection declined by 32.6 percentage points after the trial was published. The decline began immediately after the trial was presented at a medical conference. The rapid decline in the use of axillary dissection belies the common belief that practice patterns are slow to change in response to new evidence, and it highlights the value of trials of established medical practices to patients and the health system.

摘要

传统观点认为,医生放弃无效医疗实践的速度很慢。我们以腋窝淋巴结清扫术为例对这一理论进行了评估,腋窝淋巴结清扫术是一种在保乳手术后切除乳房附近淋巴结以防止乳腺癌扩散的手术。1999年至2004年进行的一项大型试验,其结果于2010年公布并于2011年发表,该试验发现符合某些标准的患者可以放弃腋窝淋巴结清扫术。利用癌症登记数据,我们估计在该试验发表后,接受腋窝清扫术的患者比例下降了32.6个百分点。在该试验在一次医学会议上公布后,下降立即开始。腋窝清扫术使用的迅速下降与普遍认为的实践模式因新证据而变化缓慢的观点相悖,它凸显了对既定医疗实践进行试验对患者和卫生系统的价值。

相似文献

1
Contrary To Conventional Wisdom, Physicians Abandoned A Breast Cancer Treatment After A Trial Concluded It Was Ineffective.与传统观念相反,在一项试验得出一种乳腺癌治疗方法无效的结论后,医生们放弃了该治疗方法。
Health Aff (Millwood). 2016 Jul 1;35(7):1309-15. doi: 10.1377/hlthaff.2015.1490.
2
The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.医院和外科医生因素对导管原位癌腋窝淋巴结评估流行率的影响。
JAMA Oncol. 2015 Jun;1(3):323-32. doi: 10.1001/jamaoncol.2015.0389.
3
[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].[早期浸润性乳腺癌前哨淋巴结活检阳性后腋窝的最佳治疗。OTOASOR试验的早期结果]
Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765.
4
Axillary dissection versus no axillary dissection in older T1N0 breast cancer patients: 15-year results of trial and out-trial patients.腋窝清扫与不清扫在老年 T1N0 乳腺癌患者中的对比:试验和试验外患者的 15 年结果。
Eur J Surg Oncol. 2014 Jul;40(7):805-12. doi: 10.1016/j.ejso.2014.03.029. Epub 2014 Apr 13.
5
Is regional nodes radiotherapy an alternative to surgery?区域淋巴结放疗是否可以替代手术?
Breast. 2013 Aug;22 Suppl 2:S118-28. doi: 10.1016/j.breast.2013.07.023.
6
Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.对于前哨淋巴结有微转移的乳腺癌患者,区域控制无需完成腋窝淋巴结清扫。
Arch Surg. 2010 Jun;145(6):564-9. doi: 10.1001/archsurg.2010.84.
7
Positive axillary sentinel lymph node: is axillary dissection always necessary?阳性腋窝前哨淋巴结:是否总是需要腋窝清扫?
Breast. 2011 Oct;20 Suppl 3:S96-8. doi: 10.1016/S0960-9776(11)70303-4.
8
Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).腋窝淋巴结清扫与 T1N0 乳腺癌患者不清扫的随机临床试验(INT09/98)。
Cancer. 2014 Mar 15;120(6):885-93. doi: 10.1002/cncr.28499. Epub 2013 Dec 5.
9
Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer.在部分淋巴结阳性乳腺癌患者中避免腋窝淋巴结清扫术。
Eur J Surg Oncol. 2008 Feb;34(2):129-34. doi: 10.1016/j.ejso.2007.03.026. Epub 2007 May 11.
10
[Management of the axilla in breast cancer: evidences and unresolved issues].[乳腺癌腋窝的管理:证据与未解决的问题]
Orv Hetil. 2001 Sep 9;142(36):1941-50.

引用本文的文献

1
Regional Nodal Management in the Setting of Up-Front Surgery.术前新辅助治疗时的区域淋巴结管理。
Semin Radiat Oncol. 2022 Jul;32(3):221-227. doi: 10.1016/j.semradonc.2022.01.004.
2
Addressing the problem of overtreatment in breast cancer.解决乳腺癌过度治疗问题。
Expert Rev Anticancer Ther. 2022 May;22(5):535-548. doi: 10.1080/14737140.2022.2064277. Epub 2022 May 19.
3
Policies and Practices to Address Cancer's Long-Term Adverse Consequences.应对癌症长期不良后果的政策和实践。
J Natl Cancer Inst. 2022 Aug 8;114(8):1065-1071. doi: 10.1093/jnci/djac086.
4
Variation in Deescalated Axillary Surgical Practices in Older Women with Early-Stage Breast Cancer.老年早期乳腺癌女性患者腋窝手术降阶梯治疗方案的差异
Ann Surg Oncol. 2022 Apr 6. doi: 10.1245/s10434-022-11677-z.
5
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.国际主要转诊中心间前哨淋巴结阳性黑色素瘤行完全淋巴结清扫术和辅助全身治疗的应用的中心水平差异。
Ann Surg. 2023 May 1;277(5):e1106-e1115. doi: 10.1097/SLA.0000000000005370. Epub 2023 Apr 6.
6
Evidence and implementation gaps in management of sentinel node-positive melanoma in the United States.美国哨兵淋巴结阳性黑色素瘤管理中的证据和实施差距。
Surgery. 2022 Jul;172(1):226-233. doi: 10.1016/j.surg.2021.12.025. Epub 2022 Feb 1.
7
Physician variation in the de-adoption of ineffective statin and fibrate therapy.医生在停用无效的他汀类药物和贝特类药物治疗方面的差异。
Health Serv Res. 2021 Oct;56(5):919-931. doi: 10.1111/1475-6773.13630. Epub 2021 Feb 10.
8
Deimplementation of the Choosing Wisely Recommendations for Low-Value Breast Cancer Surgery: A Systematic Review.取消低价值乳腺癌手术的选择明智建议的实施:系统评价。
JAMA Surg. 2020 Aug 1;155(8):759-770. doi: 10.1001/jamasurg.2020.0322.
9
Barriers and Facilitators to De-Implementation of the Choosing Wisely Guidelines for Low-Value Breast Cancer Surgery.低价值乳腺癌手术“明智选择”指南去实施的障碍与促进因素
Ann Surg Oncol. 2020 Aug;27(8):2653-2663. doi: 10.1245/s10434-020-08285-0. Epub 2020 Mar 2.
10
Physician age and the abandonment of episiotomy.医生年龄与会阴侧切术的废弃。
Health Serv Res. 2019 Jun;54(3):650-657. doi: 10.1111/1475-6773.13132. Epub 2019 Mar 6.